tiprankstipranks
Advertisement
Advertisement

AU:ILA Stock Latest News

Island Pharmaceuticals Issues New Shares on Option Exercise, Affirms Regulatory Compliance
Company AnnouncementsIsland Pharmaceuticals Issues New Shares on Option Exercise, Affirms Regulatory Compliance
6d ago
ILA
Island Pharmaceuticals Seeks Quotation for Additional 125,000 ASX Shares
PremiumCompany Announcements
Island Pharmaceuticals Seeks Quotation for Additional 125,000 ASX Shares
6d ago
ILA
Island Pharmaceuticals Issues New Shares on Option Conversion, Affirms Compliance
PremiumCompany Announcements
Island Pharmaceuticals Issues New Shares on Option Conversion, Affirms Compliance
13d ago
ILA
Island Pharmaceuticals Seeks ASX Quotation for 690,000 New Shares
PremiumCompany Announcements
Island Pharmaceuticals Seeks ASX Quotation for 690,000 New Shares
13d ago
ILA
Island Pharmaceuticals Halts Trading Ahead of Biodefence Deal Announcement
PremiumCompany Announcements
Island Pharmaceuticals Halts Trading Ahead of Biodefence Deal Announcement
1M ago
ILA
Island Pharmaceuticals posts wider half-year loss despite uptick in asset backing
PremiumCompany AnnouncementsIsland Pharmaceuticals posts wider half-year loss despite uptick in asset backing
1M ago
ILA
Island Pharmaceuticals Defends Handling of FDA Feedback in ASX Query
Premium
Company Announcements
Island Pharmaceuticals Defends Handling of FDA Feedback in ASX Query
2M ago
ILA
Island Pharmaceuticals Outlines Strategy on Urgent Viral Threats in Investor Presentation
Premium
Company Announcements
Island Pharmaceuticals Outlines Strategy on Urgent Viral Threats in Investor Presentation
2M ago
ILA
Island Pharmaceuticals Plans New Share Placement to Raise Capital
PremiumCompany Announcements
Island Pharmaceuticals Plans New Share Placement to Raise Capital
2M ago
ILA
Island Pharmaceuticals Raises A$9m to Accelerate Galidesivir Biodefence Program and US Stockpile Push
PremiumCompany Announcements
Island Pharmaceuticals Raises A$9m to Accelerate Galidesivir Biodefence Program and US Stockpile Push
2M ago
ILA
FDA Backs Island Pharmaceuticals’ Galidesivir Pathway, Opening Route to Accelerated Approval
PremiumCompany Announcements
FDA Backs Island Pharmaceuticals’ Galidesivir Pathway, Opening Route to Accelerated Approval
2M ago
ILA
Island Pharmaceuticals Requests Trading Halt Ahead of FDA Feedback on Galidesivir
PremiumCompany Announcements
Island Pharmaceuticals Requests Trading Halt Ahead of FDA Feedback on Galidesivir
2M ago
ILA
Island Pharmaceuticals Advances Clinical Programs Targeting Urgent Viral Threats
PremiumCompany AnnouncementsIsland Pharmaceuticals Advances Clinical Programs Targeting Urgent Viral Threats
2M ago
ILA
Island Pharmaceuticals Secures Key FDA Boost and US Partnerships for Galidesivir Antiviral Program
Premium
Company Announcements
Island Pharmaceuticals Secures Key FDA Boost and US Partnerships for Galidesivir Antiviral Program
2M ago
ILA
Island Pharmaceuticals Issues 8 Million Unquoted Options as Part of Capital Structure
Premium
Company Announcements
Island Pharmaceuticals Issues 8 Million Unquoted Options as Part of Capital Structure
3M ago
ILA
Island Pharmaceuticals Awaits Extended FDA Review as Galidesivir Preparations Advance
PremiumCompany Announcements
Island Pharmaceuticals Awaits Extended FDA Review as Galidesivir Preparations Advance
3M ago
ILA
Island Pharmaceuticals Secures Strategic Agreement with Texas Biomed for Galidesivir Development
PremiumCompany Announcements
Island Pharmaceuticals Secures Strategic Agreement with Texas Biomed for Galidesivir Development
4M ago
ILA
Island Pharmaceuticals Secures US Patent for Covid-19 Treatment
PremiumCompany Announcements
Island Pharmaceuticals Secures US Patent for Covid-19 Treatment
4M ago
ILA
Island Pharmaceuticals Advances Galidesivir Development with FDA Submission
PremiumCompany Announcements
Island Pharmaceuticals Advances Galidesivir Development with FDA Submission
4M ago
ILA
Island Pharmaceuticals Announces Director’s Interest Change
PremiumCompany AnnouncementsIsland Pharmaceuticals Announces Director’s Interest Change
4M ago
ILA
Island Pharmaceuticals Secures $1 Million for Antiviral Development
Premium
Company Announcements
Island Pharmaceuticals Secures $1 Million for Antiviral Development
4M ago
ILA
Island Pharmaceuticals Issues New Shares Following Option Exercise
Premium
Company Announcements
Island Pharmaceuticals Issues New Shares Following Option Exercise
4M ago
ILA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >